Search Articles — Sudonull

https://sudonull.com/hybrid-nissan-terrano-phev-2026-concept-for-russia

Nissan presented the Terrano PHEV and Urban SUV plug-in hybrid concepts at the Beijing Auto Show. Learn about the design, power, and release timelines for the production SUVs.

https://sudonull.com/vizir-vlm-ai-video-analytics-from-crt-saves-90-of-time

CRT presented «Vizir.VLM» — a vision-language model combining computer vision and AI. Learn how the solution understands video context and reduces operator workload.

https://sudonull.com/24-deep-tech-startups-of-india-what-investors-need-to-know

India presented 24 deep-tech startups in Bangalore. Analysis of the strategy to attract $85 billion, competition with China, and prospects for investors. Read the details.

https://sudonull.com/caterpillar-physical-ai-on-construction-sites-with-nvidia-thor

Caterpillar and Nvidia presented at CES 2026 autonomous heavy equipment with an AI assistant. Machines think offline and reduce accident rates. Learn about digital construction.

https://sudonull.com/china-s-quantum-computer-with-1000-qubits-breakthrough

Quantum computer on photonic chips with 3000+ qubits presented in Beijing. Learn how this will change the market and challenge IBM. Read analysis.

https://ymaho.com/iran-presented-the-us-with-a-14-point-peace-plan

Tehran demanded reparations, troop withdrawal, and a new status for the Strait of Hormuz from the US. Learn the details of the ultimatum and Washington's reaction.

https://ymaho.com/iran-presented-the-us-with-a-14-point-ultimatum

Tehran rejected the US proposal for de-escalation and put forward a counter '14-point plan'. Find out why this is a political trap for Trump and how the crisis will change oil prices. Read analysis.

https://ymaho.com/intellia-crispr-therapy-phase-3-data-on-edema-breakthrough

Intellia presented long-awaited phase III data of CRISPR therapy lonvo-z for hereditary angioedema: 87% reduction in attacks, 62% of patients attack-free. Learn about the breakthrough in in vivo genome editing.

https://ymaho.com/crispr-therapy-hae-phase-3-data-from-intellia-at-eaaci-2026

Intellia presented the long-awaited results of phase 3 of CRISPR therapy lonvoguran ziclumeran for hereditary angioedema. Reduction of attacks by 87%, 62% of patients without therapy. Learn more.

https://ymaho.com/tashe-skin-first-conscious-care-at-sochi-fashion-week-2026

Belarusian brand TaShe presented the Skin First philosophy at Sochi Fashion Week. Find out why conscious care is replacing decorative cosmetics. Read expert analysis.

https://ymaho.com/kelp-hack-two-scenarios-of-aave-crisis

LlamaRisk analysts presented two scenarios for solving Aave's problems after the Kelp bridge hack of $293 million. Find out how this will affect the market and your assets.

https://ymaho.com/crispr-gene-editing-treatment-of-hypertriglyceridemia-ctx310

CRISPR Therapeutics presented CTX310 — a one-time gene therapy that reduces triglycerides by 82% and LDL by 86%. Learn about the revolution in dyslipidemia treatment and market prospects.

https://ymaho.com/epigenome-editing-of-aging-results-of-synbiobeta-2026

At SynBioBeta 2026, cell stability engineering was presented: AI mapping of aging and proteostasis editing for treating age-related diseases. Learn the details of the breakthrough.

https://ymaho.com/kuwait-prevented-irgc-sabotage-on-bubiyan-island

Arrest of IRGC officers on Bubiyan Island: how Kuwait foiled Iran's operation against Mubarak Port. Analysis of risks for the Gulf, China, and oil markets. Read insights.

https://ymaho.com/ferrari-shares-plummet-8-4-after-luce-electric-car-presentation-reasons

Why did Ferrari shares fall 8.4% after the EV Luce reveal? Analysis of market reaction, design crisis, and 30-90 day forecast. Read details.